DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: Since the results of comparative proteomic studies of muscular dystrophy and the determination of secondary effects downstream of dystrophin deficiency have previously been reviewed [23], [24], [25], these aspects of the proteomic analysis of the dystrophin complex will not be covered in detail.